{"transactions":[{"id":1757932,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2023-10-18T20:21:32.000Z","date":"2023-10-16","kind":"sale","planned":false,"acquired":false,"shares":1690663,"price":7.5,"value":12679972.5,"ownership":{"direct":true},"balance_after":3381326,"source":{"system":"sec-edgar","filing":"0001387131-23-012379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713123012379/ownership.xml","form_type":"4"}},{"id":2026186,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2023-02-09T01:10:00.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":2187511,"price":8.5,"value":18593843.5,"ownership":{"direct":true},"balance_after":5071989,"source":{"system":"sec-edgar","filing":"0001387131-23-001621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713123001621/ownership.xml","form_type":"4"}},{"id":2030222,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2023-02-06T21:18:12.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":37043,"price":11.04,"value":408954.72,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Inadvertently filed late due to an administrative error."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Issuer shares were previously held of record by Medytox Korea Co., Ltd. (\"Medytox Korea\"). Medytox, Inc. owns 100% of Medytox Korea. Accordingly, Medytox, Inc. may be deemed to beneficially own indirectly the shares by reason of Medytox Korea's direct beneficial ownership."}],"balance_after":7259500,"source":{"system":"sec-edgar","filing":"0001387131-23-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713123001468/ownership.xml","form_type":"4"}},{"id":2030221,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2023-02-06T21:18:12.000Z","date":"2021-08-13","kind":"purchase","acquired":true,"shares":14043,"price":11.1133,"value":156064.0719,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Inadvertently filed late due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.91 to $11.26, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Issuer shares were previously held of record by Medytox Korea Co., Ltd. (\"Medytox Korea\"). Medytox, Inc. owns 100% of Medytox Korea. Accordingly, Medytox, Inc. may be deemed to beneficially own indirectly the shares by reason of Medytox Korea's direct beneficial ownership."}],"balance_after":7296543,"source":{"system":"sec-edgar","filing":"0001387131-23-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713123001468/ownership.xml","form_type":"4"}},{"id":2030220,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2023-02-06T21:18:12.000Z","date":"2021-08-12","kind":"purchase","acquired":true,"shares":23000,"price":10.9902,"value":252774.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Inadvertently filed late due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.88 to $11.10, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 to 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Issuer shares were previously held of record by Medytox Korea Co., Ltd. (\"Medytox Korea\"). Medytox, Inc. owns 100% of Medytox Korea. Accordingly, Medytox, Inc. may be deemed to beneficially own indirectly the shares by reason of Medytox Korea's direct beneficial ownership."}],"balance_after":7282500,"source":{"system":"sec-edgar","filing":"0001387131-23-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713123001468/ownership.xml","form_type":"4"}},{"id":2140216,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-10-07T20:12:29.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":38304,"price":8.9917,"value":344418.0768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.95 to $9.02, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7259500,"source":{"system":"sec-edgar","filing":"0001387131-22-010336","document":"eols-form4_100622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713122010336/eols-form4_100622.xml","form_type":"4"}},{"id":2141058,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-10-06T20:18:48.000Z","date":"2022-10-05","kind":"sale","acquired":false,"shares":6848,"price":8.95,"value":61289.6,"ownership":{"direct":true},"balance_after":7297804,"source":{"system":"sec-edgar","filing":"0001839882-22-023112","document":"eols-form4_100522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000183988222023112/eols-form4_100522.xml","form_type":"4"}},{"id":2156954,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-09-16T20:10:31.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":24000,"price":10.3377,"value":248104.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.43, inclusive."}],"balance_after":7304652,"source":{"system":"sec-edgar","filing":"0001387131-22-009830","document":"eols-form4_091422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713122009830/eols-form4_091422.xml","form_type":"4"}},{"id":2156953,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-09-16T20:10:31.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":73000,"price":10.2695,"value":749673.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.54, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) and (2) to this Form 4."}],"balance_after":7328652,"source":{"system":"sec-edgar","filing":"0001387131-22-009830","document":"eols-form4_091422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713122009830/eols-form4_091422.xml","form_type":"4"}},{"id":2160992,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-09-12T21:45:16.000Z","date":"2022-09-09","kind":"sale","acquired":false,"shares":20700,"price":10.5271,"value":217910.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $10.70, inclusive."}],"balance_after":7401652,"source":{"system":"sec-edgar","filing":"0001387131-22-009717","document":"eols-form4_090822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713122009717/eols-form4_090822.xml","form_type":"4"}},{"id":2160991,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-09-12T21:45:16.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":15300,"price":10.3908,"value":158979.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.34 to $10.50, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form4."}],"balance_after":7422352,"source":{"system":"sec-edgar","filing":"0001387131-22-009717","document":"eols-form4_090822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713122009717/eols-form4_090822.xml","form_type":"4"}},{"id":2195253,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2022-08-03T20:08:17.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":26000,"price":13.2831,"value":345360.6,"ownership":{"direct":true},"balance_after":7437652,"source":{"system":"sec-edgar","filing":"0001387131-22-008344","document":"eols-form4_082721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713122008344/eols-form4_082721.xml","form_type":"4"}},{"id":2584656,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-31T20:19:02.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":51000,"price":10.9327,"value":557567.7,"ownership":{"direct":true},"balance_after":7463652,"source":{"system":"sec-edgar","filing":"0001387131-21-009158","document":"eols-form4_082721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121009158/eols-form4_082721.xml","form_type":"4"}},{"id":2587864,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-27T20:21:28.000Z","date":"2021-08-26","kind":"purchase","acquired":true,"shares":66000,"price":11.0213,"value":727405.8,"ownership":{"direct":true},"balance_after":7412652,"source":{"system":"sec-edgar","filing":"0001387131-21-009024","document":"eols-form4_082521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121009024/eols-form4_082521.xml","form_type":"4"}},{"id":2587863,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-27T20:21:28.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":44000,"price":11.1224,"value":489385.6,"ownership":{"direct":true},"balance_after":7346652,"source":{"system":"sec-edgar","filing":"0001387131-21-009024","document":"eols-form4_082521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121009024/eols-form4_082521.xml","form_type":"4"}},{"id":2590512,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-25T20:21:34.000Z","date":"2021-08-24","kind":"purchase","acquired":true,"shares":72219,"price":11.1748,"value":807032.8812,"ownership":{"direct":true},"balance_after":7302652,"source":{"system":"sec-edgar","filing":"0001387131-21-008933","document":"medytox-form4_082321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008933/medytox-form4_082321.xml","form_type":"4"}},{"id":2590511,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-25T20:21:34.000Z","date":"2021-08-23","kind":"purchase","acquired":true,"shares":69781,"price":11.0313,"value":769775.1453,"ownership":{"direct":true},"balance_after":7230433,"source":{"system":"sec-edgar","filing":"0001387131-21-008933","document":"medytox-form4_082321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008933/medytox-form4_082321.xml","form_type":"4"}},{"id":2593306,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-23T20:26:12.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":48000,"price":10.5562,"value":506697.6,"ownership":{"direct":true},"balance_after":7160652,"source":{"system":"sec-edgar","filing":"0001387131-21-008879","document":"medytox-form4_081921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008879/medytox-form4_081921.xml","form_type":"4"}},{"id":2593305,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-23T20:26:12.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":55000,"price":10.5111,"value":578110.5,"ownership":{"direct":true},"balance_after":7112652,"source":{"system":"sec-edgar","filing":"0001387131-21-008879","document":"medytox-form4_081921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008879/medytox-form4_081921.xml","form_type":"4"}},{"id":2595854,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-19T20:15:26.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":45000,"price":10.535,"value":474075.0,"ownership":{"direct":true},"balance_after":7057652,"source":{"system":"sec-edgar","filing":"0001387131-21-008746","document":"medytox-form4_081721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008746/medytox-form4_081721.xml","form_type":"4"}},{"id":2595853,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-19T20:15:26.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":70000,"price":10.6866,"value":748062.0,"ownership":{"direct":true},"balance_after":7012652,"source":{"system":"sec-edgar","filing":"0001387131-21-008746","document":"medytox-form4_081721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008746/medytox-form4_081721.xml","form_type":"4"}},{"id":2599310,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-17T20:10:59.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":65000,"price":11.339,"value":737035.0,"ownership":{"direct":true},"balance_after":6942652,"source":{"system":"sec-edgar","filing":"0001387131-21-008661","document":"medytox-form4_081321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008661/medytox-form4_081321.xml","form_type":"4"}},{"id":2599309,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-17T20:10:59.000Z","date":"2021-08-13","kind":"purchase","acquired":true,"shares":49714,"price":10.9771,"value":545715.5494,"ownership":{"direct":true},"balance_after":6877652,"source":{"system":"sec-edgar","filing":"0001387131-21-008661","document":"medytox-form4_081321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008661/medytox-form4_081321.xml","form_type":"4"}},{"id":2603328,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-13T20:33:05.000Z","date":"2021-08-12","kind":"purchase","acquired":true,"shares":39126,"price":10.9317,"value":427713.6942,"ownership":{"direct":true},"balance_after":6827938,"source":{"system":"sec-edgar","filing":"0001387131-21-008519","document":"medytox-form4_081121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008519/medytox-form4_081121.xml","form_type":"4"}},{"id":2603327,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":108902,"kind":"organization","name":"Medytox Inc.","position":1,"cik":"0001848514","reported_name":"Medytox Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.00001 par value per share","published_at":"2021-08-13T20:33:05.000Z","date":"2021-08-11","kind":"purchase","acquired":true,"shares":26160,"price":10.7698,"value":281737.968,"ownership":{"direct":true},"balance_after":6788812,"source":{"system":"sec-edgar","filing":"0001387131-21-008519","document":"medytox-form4_081121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000138713121008519/medytox-form4_081121.xml","form_type":"4"}}]}